Phibro Animal Health (NASDAQ:PAHC) Issues Earnings Results

Phibro Animal Health (NASDAQ:PAHC) issued its quarterly earnings results on Wednesday. The company reported $0.54 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.40 by $0.14, Zacks reports. Phibro Animal Health had a return on equity of 21.59% and a net margin of 1.67%. Phibro Animal Health updated its FY 2025 guidance to 1.870-2.010 EPS.

Phibro Animal Health Trading Up 5.7 %

Shares of PAHC traded up $1.29 during midday trading on Thursday, hitting $23.66. The stock had a trading volume of 90,379 shares, compared to its average volume of 138,189. The business has a 50-day simple moving average of $21.89 and a two-hundred day simple moving average of $21.60. The firm has a market cap of $958.03 million, a P/E ratio of 54.81, a price-to-earnings-growth ratio of 0.56 and a beta of 0.52. The company has a current ratio of 3.23, a quick ratio of 1.69 and a debt-to-equity ratio of 1.81. Phibro Animal Health has a fifty-two week low of $10.03 and a fifty-two week high of $25.98.

Phibro Animal Health Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, March 26th. Shareholders of record on Wednesday, March 5th will be issued a dividend of $0.12 per share. The ex-dividend date is Wednesday, March 5th. This represents a $0.48 annualized dividend and a yield of 2.03%. Phibro Animal Health’s payout ratio is presently 111.63%.

Analyst Upgrades and Downgrades

A number of research firms recently issued reports on PAHC. Morgan Stanley lifted their target price on Phibro Animal Health from $20.00 to $25.00 and gave the stock an “equal weight” rating in a report on Tuesday, December 17th. Barclays lifted their price objective on shares of Phibro Animal Health from $13.00 to $20.00 and gave the stock an “underweight” rating in a research note on Tuesday, November 12th. Finally, StockNews.com raised shares of Phibro Animal Health from a “buy” rating to a “strong-buy” rating in a research note on Wednesday, January 29th. Two investment analysts have rated the stock with a sell rating, two have assigned a hold rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus price target of $20.50.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.